Oncology News, Insights, Stories by OncoDaily

London Global Cancer Week (LGCW) 2025
2025-11-24 - 2025-11-28 | TN
The London Global Cancer Week (LGCW) 2025 is a week-long series of multi-disciplinary, collaborative events scheduled from November 24 to 28, 2025, in London, UK. LGCW acts as a catalyst for change, convening professional bodies, universities, policy makers, private sector companies, and charities to focus on the global cancer challenge, particularly the disproportionate burden on low- and middle-income countries (LMICs). The week’s diverse programs, presented by a variety of hosts, will highlight innovative solutions, showcase global cancer control initiatives, and promote coherence in policymaking at national and international levels, with no charge for organizations to present or for people to attend.

AGITG 27th Annual Scientific Meeting
2025-11-24 - 2025-11-27 | Adelaide Convention Centre, North Terrace, Adelaide, South Australia, 5000, Australia
The 27th Annual Scientific Meeting of the Australasian Gastrointestinal Trials Group (AGITG) is a four-day conference focused on advancing GI cancer research through partnership.
Held in Tarntanya/Adelaide from November 24–27, 2025, the event’s theme is “Transforming Trials through Collaboration,” highlighting the need for global cooperation and engagement with Aboriginal and Torres Strait Islander communities to enhance clinical trial accessibility and impact. The program features workshops, the New Concepts Symposium, and presentations from international experts, all while incorporating patient perspectives to ensure research relevance.

Best of ESMO Gulf 2025
2025-11-22 - 2025-11-23 | Grand Plaza Mövenpick Media City, Al Falak Street, Opposite Innovation Hub, Dubai Media City, Dubai, 502713, United Arab Emirates
The Best of ESMO Gulf 2025, organized by the Emirates Oncology Society, will take place on 22–23 November 2025 at the Grand Plaza Mövenpick Media City, Dubai.
This hybrid event brings together delegates, faculty, and industry partners to showcase the latest advancements in breast, gastrointestinal, genitourinary, and lung cancers, as presented at the ESMO 2025 Congress in Berlin. It is a premier platform for knowledge exchange and collaboration, advancing excellence in oncology care across the region.

ECHoS Town Hall Meeting
2025-11-21 09:00 - 13:00 (America/Halifax) | Radisson Collection Hotel, Grand Place Brussels, Rue du Fossé aux Loups 47, Bruxelles (Brussels), Bruxelles, 1000, Belgium
The ECHoS Town Hall Meeting is a landmark event centered on the implementation of the Horizon Europe ECHoS project, which is dedicated to establishing national hubs across EU countries to better coordinate cancer care by integrating research, policy, and innovation. This gathering is designed to facilitate high-level discussion among key stakeholders, including policymakers, researchers, and patient representatives, to collectively assess the effectiveness of these hubs and their strategic role.
The primary objective of the meeting is to discuss how these new coordination hubs are actively advancing the core goals of the EU Mission on Cancer and Europe’s Beating Cancer Plan. Held on November 21st from 09:00 to 13:00 CET at the Radisson Collection Hotel in Brussels, the event is framed as a crucial opportunity to network, share expert insights, and explore new collaborative solutions to fundamentally shape the future of cancer research and care throughout Europe.
Register.

You can find more posts featuring ECHoS on OncoDaily.

Best of ESMO 2025 Vilnius
2025-11-21 08:30 - 18:35 (Europe/Vilnius) | Radisson BLU Hotel Lietuva, Konstitucijos pr. 20, Vilnius, 09308, Lithuania
The Hybrid Conference “Best of ESMO 2025,” an ESMO Licensed Event, will take place on 21 November at Radisson BLU Hotel Lietuva in Vilnius, Lithuania.
Organized by the Lithuanian Society for Medical Oncology, the event offers both in-person and remote participation, with an 8-hour qualification certificate for all attendees. Registration is free but mandatory, and transportation will be arranged from major Lithuanian cities upon request.
It brings together leading experts to present and discuss cutting-edge cancer research, emerging therapies, and clinical innovations from the European Society for Medical Oncology (ESMO) 2025 congress. The event is designed to update oncologists and healthcare professionals on state-of-the-art cancer treatments, biomarkers, and best practices in patient care.

IASLC 2025 Hot Topic in Basic and Translational Science: Unraveling Precancer and Early-Stage Lung Cancer
2025-11-21 - 2025-11-23 | Hilton Tokyo, 6-6-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Shinjuku, 160-0023, Japan
The IASLC 2025 Hot Topic in Basic and Translational Science: Unraveling Precancer and Early-Stage Lung Cancer meeting is a three-day event in Tokyo, Japan, dedicated to advancing the understanding and treatment of early lung cancer. Scheduled to begin on November 21, 2025, the meeting focuses on the molecular, genomic, transcriptomic, and immune mechanisms of early lung carcinogenesis. It aims to bridge the gap between basic science and clinical application by exploring emerging biomarker and diagnostic innovations (including liquid biopsies and AI) and discussing novel therapeutic pathways like targeted therapies and immunotherapy for the earliest stages of the disease.

ESMO Advanced Course on Cholangiocarcinoma 2025: Barcelona
2025-11-21 - 2025-11-22 | Hotel Barcelona Center, Carrer de Balmes, 103‑105, Eixample, Barcelona, 08008, Spain
The ESMO Advanced Course on Cholangiocarcinoma 2025 will be held on 21–22 November 2025 at the Hotel Barcelona Center in Barcelona, Spain.
This course provides a comprehensive update on the diagnosis, molecular profiling, and management of cholangiocarcinoma, covering surgery, locoregional therapies, immunotherapy, targeted treatments, and both adjuvant and palliative strategies. Accredited with 11 ESMO-MORA points, the program is designed to enhance the knowledge and clinical skills of medical oncologists managing this challenging malignancy.

ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025: Barcelona
2025-11-21 - 2025-11-22 | TN
The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025 will be held on 21–22 November 2025 in Barcelona, Spain.
This course, chaired by Prof. Javier Cortés and Prof. Nadia Harbeck, provides an in-depth exploration of antibody-drug conjugates (ADCs), covering drug development, mechanisms of action, integration into clinical practice, and management of associated toxicities. Accredited with 9 ESMO-MORA category 1 points, it offers participants a comprehensive platform to advance their knowledge and expertise in breast cancer therapeutics.

The ESO Refresher Course on Breast Cancer
2025-11-21 - 2025-11-23 | TN
The ESO Refresher Course on Breast Cancer is a training program designed for medical, surgical, and radiation oncologists, pathologists, and radiologists involved in breast cancer management. Scheduled for November 21-23, 2025, in Sofia, Bulgaria, the course offers interactive, case-based sessions including tumor board discussions led by experts.
It focuses on the latest diagnostic and therapeutic strategies, patient-centered care, and shared decision-making to improve clinical outcomes and quality of life for breast cancer patients. The course is practical and multidisciplinary, ideal for deepening clinical skills and knowledge. The official language will be English. No translation will be available.

The SIOG 2025 Annual Conference
2025-11-20 08:00 - 2025-11-22 17:00 (America/Halifax) | International Convention Centre of Ghent, Citadelpark 1, Ghent, 9000
The SIOG 2025 Annual Conference will take place in person from 20 to 22 November 2025 at the International Convention Centre of Ghent (Gent ICC) in Belgium.
This in-person event will bring together experts, researchers, and professionals in the field of geriatric oncology to share knowledge and discuss the latest advancements in the discipline. Remote participation will not be available, so all attendees will need to be present at the conference venue in Ghent to participate. With the theme of “Bridging Research and Clinical Practice in Geriatric Oncology”, the event emphasizes the need for integrating scientific discoveries into clinical care to improve outcomes for older cancer patients.
In 2025, there will be no specific tracks for abstract submissions, meaning that all proposals related to geriatric oncology will be considered for presentation, provided they follow the submission guidelines. The conference welcomes submissions from a variety of disciplines, including those historically under-represented in the field, such as surgical oncology and radiation oncology. This open approach allows for a wide range of topics to be addressed, encouraging diverse contributions to the scientific programme and fostering a rich exchange of knowledge across specialties in geriatric oncology.

ASYGO-ENYGO 1st Joint Webinar: Training and Surgical Education in Gynecologic Oncology - Asia vs Europe
2025-11-20 | TN
The ASYGO-ENYGO 1st Joint Webinar, titled “Training and Surgical Education in Gynecologic Oncology – Asia vs Europe,” is a collaborative event between the Asian Society of Young Gynecologic Oncologists (ASYGO) and the European Network of Young Gynae Oncologists (ENYGO).
Scheduled for Thursday, November 20, 2025, at 20:00 KST (Korean Standard Time) / 13:00 CET (Central European Time), the webinar aims to be the first of its kind to analyze the current state of gynecologic oncology training and surgical education across Asia and Europe.
The joint event will feature a pan-Asian survey on gynecologic oncology training, presentations from both trainees and mentors, and discussions on innovative initiatives, offering a crucial platform for knowledge exchange, addressing shared challenges, and shaping the future direction of training in the field.
Register.

EACR-yEHA-yEFIS Webinar on CAR T-Cells
2025-11-19 14:00 - 15:30 (America/Halifax) | TN
The EACR-yEHA-yEFIS Webinar on CAR T-cells is a free virtual event scheduled for Wednesday, November 19, 2025, from 14:00 – 15:30 CET.
Hosted collaboratively by the European Association for Cancer Research (EACR), the Young European Hematology Association (yEHA), and the Young European Federation of Immunological Societies (yEFIS), the webinar focuses on discussing the potential of CAR T-cells for the treatment of both hematological malignancies and solid tumors.
The session will include presentations from experts in the field, such as Dr. Sonia Guedan (IDIBAPS), Dr. med. David Stahl (University Hospital Cologne), and Dr. med. Tobias Weiss (University of Zurich), followed by an interactive Q&A session.

European Cancer Summit 2025
2025-11-19 09:00 - 2025-11-20 17:00 (America/Halifax) | Radisson Collection Hotel, Grand Place Brussels, Rue du Fossé aux Loups 47, Bruxelles (Brussels), Bruxelles, 1000, Belgium
The European Cancer Summit 2025, organized by the European Cancer Organisation (ECO), will be held on November 19th–20th in Brussels, Belgium, at the Radisson Collection Hotel, Grand Place Brussels (with an online option). The theme for this year’s summit is: “Cancer in a Changing Global Landscape: Challenges and Commitments.”
The summit’s core objective is to unite the broad cancer community to secure sustained political and financial support for cancer care as a health and societal priority, particularly in an era of global disruption. The event will serve as a high-level, multi-stakeholder forum, bringing together healthcare professionals, patients, and policymakers – including several MEPs and the European Commissioner for Health and Animal Welfare – to discuss challenges, safeguard patient care, and ensure the achievements of Europe’s Beating Cancer Plan and the Cancer Mission are maintained.
You can find more posts featuring ECO on OncoDaily.

ILCA Annual Conference 2025
2025-11-19 08:00 - 2025-11-21 17:00 (Asia/Hong_Kong) | Hong Kong, Hong Kong, China
ILCA Annual Conference 2025 will be held from 19-21 November, 2025 at Hong Kong.
The ILCA25 program will explore key topics in liver cancer, from basic and translational research to clinical management for patients with primary liver cancer, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Attendees will engage with the latest advances in screening, diagnosis, treatment, and survivorship.
International experts will lead in-depth presentations and interactive discussions, offering new insights on the most pressing issues in liver cancer care. With a focus on open dialogue and future perspectives, this event promises to spark paradigm shifts in both clinical practice and research.
Super early-bird rates are available until 7 April, 2025.

OHOS Annual Fall Meeting
2025-11-19 | Quest Conference Center – Polaris, 9200 Worthington Rd Ste 400, 9200 Worthington Rd Ste 400, OH, 43082, United States
The OHOS 2025 Annual Fall Meeting is a critical, single-day conference hosted by the Ohio Hematology Oncology Society (OHOS) on Wednesday, November 19, 2025, at the Quest Conference Center in Columbus, Ohio.
Focused on the theme, “Protecting Access and Preparing for 2026,” the meeting provides oncology professionals with essential updates on anticipated 2026 Medicare Final Rules from experts like ASCO’s Director of Payment Access, state legislative changes, and direct networking with payers and industry representatives to ensure continued access to quality cancer care.

ESID-EHA-SIOPE Focused Symposium 2025
2025-11-18 00:00 - 2025-11-20 00:00 (America/Sao_Paulo) | Vienna, Austria, Vienna, 1300, Austria
ESID-EHA-SIOPE Focused Symposium 2025 will take place in Vienna, 18-20 November 2025.

The ESID-EHA-SIOPE 2025 symposium will be a landmark event that brings together leading experts from the fields of immunology, haematology, and paediatric oncology to explore the critical intersections between these specialties. Titled “The Interplay of Immunology and Haematology” the symposium aims to foster collaboration and discussion on how advancements in each of these areas can improve the diagnosis, treatment, and management of patients with complex, multi-faceted conditions. The event promises an immersive experience where professionals will share their insights and innovative approaches in addressing the evolving challenges in patient care.
As patient cases become increasingly intricate, these specialties are more interconnected than ever before. The symposium will provide a unique platform to explore the complex relationships between immunodeficiencies, hematologic, and oncologic conditions, helping clinicians develop more comprehensive, multidisciplinary approaches. Participants will have the opportunity to examine pathophysiological links among these fields, discussing the latest best practices for screening, integrated treatment, and patient management. With a focus on driving better patient outcomes through collective expertise, the event will encourage deep discussions on how collaboration across these fields can enhance patient care and treatment efficacy.
The ESID-EHA-SIOPE 2025 symposium will also feature cutting-edge research, with an emphasis on scientific discovery and its application in clinical practice. Attendees can expect to learn about the latest breakthroughs in immunodeficiencies, haematology, and oncology, and contribute to the growing body of knowledge in these fields. The event is particularly encouraging for fellows, researchers, and junior faculty, offering a platform for them to present and discuss novel basic and clinical information. By uniting experts from three pivotal societies, this symposium marks a new era of collaboration, with the shared goal of improving patient outcomes through a multidisciplinary approach to complex health challenges.
For Registration, visit here.
For Abstract Submission, visit here.

World Cancer Leaders’ Summit 2025
2025-11-18 00:00 - 2025-11-20 00:00 UTC | TN
The World Cancer Leaders’ Summit 2025 will take place in Melbourne, Australia, on November 18-20.
This important event, held every two years, serves as a key forum for coordinating a global response to the growing cancer epidemic.
Hosted by Cancer Council Victoria, a full UICC member, along with co-hosts like the VCCC Alliance, Monash Partners Comprehensive Cancer Consortium, and the McCabe Centre for Law and Cancer, the summit brings together experts from various international cancer alliances.
It also partners with organizations such as the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC).
Join global leaders in cancer care and research to collaborate on strategies for tackling this pressing issue.
Find more information featuring WCLS2023 at OncoDaily.com.

5th Cancer Council/AEA Cancer SIG ECR Conference
2025-11-17 19:00 - 2025-11-18 02:00 (America/Halifax) | TN
The Cancer Council / AEA Cancer SIG ECR Conference is a free, virtual, single-day event designed for Early Career Researchers (ECRs) working in cancer epidemiology, jointly organized by the Cancer Council and the Australasian Epidemiological Association (AEA) Cancer Special Interest Group (SIG).
Scheduled for November 18, 2025, from 10:00 AM to 5:00 PM (AEDT), the conference provides an essential opportunity for ECRs affiliated with the Cancer Council (including the Daffodil Centre) and/or financial AEA members to present and share their latest research findings within the field.

International Conference on Cancer Science and Research (CANCER 2025)
2025-11-17 - 2025-11-19 | Village Hotel Changi, 1 Netheravon Rd, Singapore 508502, Singapore, 508502, Singapore
The International Conference on Cancer Science and Research (CANCER 2025) is a hybrid event dedicated to advancing global knowledge and collaboration in oncology, running from November 17-19, 2025, in Singapore and Online, under the theme “Oncology Nexus – Innovate, Collaborate, Conquer Cancer.” This premier global meeting will gather leading researchers, oncologists, healthcare professionals, and industry experts to discuss the latest breakthroughs across a wide range of cancer science topics, including molecular biology, immunotherapy, and early detection, featuring keynote sessions, oral and poster presentations, and dynamic panel discussions focused on fostering collaborative research and improving patient care.

Molecular and Cellular Hallmarks of Aging: 3rd Edition
2025-11-17 - 2025-11-19 | CNIO Auditorium, C/ Melchor Fernández Almagro, 3, Madrid, Community of Madrid, 28029, Spain
The “Molecular and Cellular Hallmarks of Aging: 3rd Edition” conference is a three-day scientific meeting, organized by the Spanish National Cancer Research Centre (CNIO). The event is scheduled to take place from 17 to 19 November 2025 at the CNIO Auditorium in Madrid, Spain. This conference is co-organized by CNIO faculty members Maria Blasco and Alejo Efeyan, alongside Thomas Rando (US), bringing together leading experts to discuss the latest research into the molecular and cellular mechanisms that drive the aging process.

Young Adult Cancers Symposium by Vanderbilt-Ingram Cancer Center
2025-11-15 08:00 - 15:00 (America/Halifax) | The Listening Room Cafe, Nashville, TN, 618 4th Avenue South, Nashville, TN 37210, Nashville, TN, 37210, United States
The Young Adult Cancers Symposium, hosted by the Vanderbilt-Ingram Cancer Center (VICC), is a CME-accredited, multidisciplinary event scheduled for Saturday, November 15, 2025, from 8:00 AM to 3:00 PM. The symposium’s mission is to empower young adults aged 20-45 who are affected by cancer. It will be held at a unique Nashville venue, The Listening Room Cafe (618 4th Avenue South). The program focuses on addressing the unique challenges this demographic faces, with sessions covering critical topics such as fertility preservation, financial toxicity, survivorship, and the treatment of breast, colorectal, and hematologic cancers.
The symposium features an impressive lineup of nationally renowned faculty from top institutions, including VICC, Dana-Farber Cancer Institute, MD Anderson Cancer Center, and Fred Hutchinson Cancer Center. While the event does have a fee (varying by attendee type, e.g., Physicians, Other Healthcare Providers, and Survivors/Patients), the organizers are supporting the community by offering free registration to the first 100 registered survivors/patients. Attendees can also earn up to 6 AMA PRA Category 1 Credits™. Additionally, a social Meet-and-Greet reception will be held the evening before the symposium on November 14th in Nashville.
You can find more posts on Young Adult Cancers on OncoDaily.

PSOH Fall 2025 Annual Meeting
2025-11-15 07:45 - 15:45 (America/Halifax) | Penn Harris Hotel, 1150 Camp Hill Bypass, Camp Hill, PA, 17011, United States
The PSOH (Pennsylvania Society of Oncology and Hematology) Fall 2025 Annual Meeting is a one-day educational event designed to bring “Breakthroughs to the Community” for oncology and hematology professionals. Scheduled for Saturday, November 15, 2025, the meeting will be held at the Penn Harris Hotel in Camp Hill, Pennsylvania. Key agenda items include an overview of Artificial Intelligence in Cancer Care, legislative updates, a Breast Cancer Management Roundtable, and sessions on Sickle Cell Disease and Bi-specific Antibodies in Community Oncology. The event is accredited for CME credits and serves as a vital platform for practitioners to receive quality, relevant education and network with peers.

2nd Asia-Pacific Cardio-Oncology Summit
2025-11-15 - 2025-11-16 | Golden Tulip, 2nd Cross Road Dd 19, DD-19, 3rd Ave, DD Block, Sector 1, Bidhannagar, Kolkata, West Bengal, 700064, India
The 2nd Asia-Pacific Cardio-Oncology Summit is a premier event hosted by the Asia Pacific Cardio Oncology Society (ACOS) to foster growth and collaboration in the rapidly evolving field of Cardio-Oncology across the Asia-Pacific region.
Scheduled for November 15–16, 2025, in Kolkata, India, the summit is officially endorsed by the International Cardio-Oncology Society (ICOS) and led by:

Program Director: Dr. Vivek Agarwala
Chief Scientific Chair: Dr. Purvish Parikh
Keynote Highlight: Be sure to catch Dr. Arjun Ghosh’s Keynote Lecture on the cutting-edge topic, “Big Data and Emerging Technologies in Cardio-Oncology.”

Register.

MSCO 2025 Annual Meeting
2025-11-14 18:30 - 21:45 (America/Halifax) | DoubleTree by Hilton Hotel Boston, 5400 Computer Drive, Westborough, MA, 01581, United States
The MSCO 2025 Annual Meeting, hosted by the Massachusetts Society of Clinical Oncologists (MSCO), is a specialized evening event scheduled for November 14, 2025, from 5:30 PM to 8:45 PM, at the DoubleTree by Hilton Hotel Boston in Westborough, MA.
The meeting focuses on advancing exemplary cancer care in Massachusetts, featuring a comprehensive agenda of state legislative updates, presentations on cutting-edge research in oncology, and the presentation of various professional awards and grants (like the Young Investigator Award and Cancer Survivorship Grant) to recognize and support oncology professionals and trainees in the state.

Achieving Health Equity in Cancer Care
2025-11-14 08:00 - 17:00 (America/Halifax) | Mortimer B. Zuckerman Research Center, 417 East 68th Street, New York, NY, 10065, United States
The conference, Achieving Health Equity in Cancer Care: Harnessing the Power of Research, Technology, and Community-Based Partnerships, is a complimentary, one-day event presented by Memorial Sloan Kettering Cancer Center (MSK) and MediSys Health Network.
It is scheduled for Friday, November 14, 2025, from 8:00 AM to 5:00 PM, and will be held exclusively in-person at the Zuckerman Research Center, 417 East 68th Street, New York, NY, USA. The conference is aimed at all healthcare providers and is focused on exploring actionable strategies to advance health equity in underserved populations by examining the role of technology, the geography of disease, academic-community partnerships, and care delivery through strong community ties.
Register.

Basics in Breast Cancer Surgery Course by ESO
2025-11-14 - 2025-11-15 | Imperial College London, Exhibition Rd, South Kensington,, London, London SW7 2AZ
“Basics in Breast Cancer Surgery” Practical Training Course, orginazed by European School of Oncology, will take a place on November 14 or 15, 2025.
This educational course offers a comprehensive overview of modern Breast Cancer Surgery, combining cancer control with cosmetic outcome considerations. It covers fundamental knowledge of tumor biology and disease spread, alongside detailed explanations of key procedures such as sentinel node biopsy, axillary dissection, and removal of non-palpable lesions. Participants will have a hands-on opportunity to perform and critically evaluate these techniques using custom-made models (one model per participant).
The program consists of two parts:
1. Pre-recorded online lectures available from September 15, 2025, which participants must watch before the in-person event.
2. An in-person event on November 14 or 15, 2025, accommodating up to 14 participants per day with identical programs each day.

17th European Multidisciplinary Congress on Urological Cancers
2025-11-13 - 2025-11-16 | TN
The 17th European Multidisciplinary Congress on Urological Cancers (EMUC 2025) is a highly specialized event organized by the European Society for Medical Oncology (ESMO). This congress is focused entirely on urological cancers, bringing together top experts from various fields including medical oncology, pathology, radiation oncology, and urology to discuss best practices, major trial developments, and breakthroughs. Scheduled to take place in Prague, Czech Republic, from 13 to 16 November 2025, the event emphasizes essential updates, popular hands-on training courses, and eye-opening multidisciplinary case discussions to advance treatment and care for genitourinary (GU) cancers.
You can find more posts featuring EMUC25 on OncoDaily.

XXXVI Congress of the Hungarian Society of Oncologists
2025-11-13 - 2025-11-15 | Hotel Azur, Erkel Ferenc u. 2/C, Siófok, 8600, Hungary
The XXXVI Congress of the Hungarian Society of Oncologists (MOT) will take place from 13 to 15 November 2025 in Siófok, Hungary. The specific venue for the event is the Hotel Azur. This major professional meeting for Hungarian oncology will present a comprehensive scientific program covering all aspects of the discipline, including diagnostics, the three main treatment modalities, palliative and supportive care, and their innovative cooperation, alongside basic and translational research and new therapeutic directions, with the goal of advancing comprehensive oncology care and improving patient benefits.

The ESMO AI and Digital Oncology Congress 2025
2025-11-12 08:00 - 2025-11-14 17:00 (Europe/Berlin) | Messe Berlin, Messedamm 22, Berlin, 14055, Germany
The ESMO AI and Digital Oncology Congress 2025 will be held from 12–14 November in Berlin, Germany.
This event offers a dynamic platform for exploring the intersection of artificial intelligence, digital technologies, and oncology. With a focus on the latest research, ethical considerations, and technological innovations, the congress brings together clinicians, researchers, technologists, and healthcare leaders to discuss how digital tools are reshaping cancer care.
Designed to foster collaboration across disciplines, the congress provides valuable insights into how AI and digital health solutions can enhance diagnosis, treatment, and patient outcomes. It’s an essential event for cancer care professionals aiming to stay ahead in the digital transformation of oncology.
Registration is Open for the Event.

FGB-FM-ESO Joint International Conference 2025
2025-11-12 - 2025-11-13 | Fondazione Prada, L.go Isarco, 2, 20139 Milano MI
The FGB-FM-ESO Joint International Conference 2025, organized by the European School of Oncology, will take place from 12-13 November 2025. This event brings together global experts in oncology to present recent advances in cancer therapeutics, including novel drug delivery systems and targeted therapies. It also highlights the integration of artificial intelligence across the cancer care continuum, from diagnosis to treatment selection.
The conference is designed to facilitate knowledge transfer between research and clinical practice, encourage collaboration between established and emerging professionals, and address practical challenges in implementing new technologies in oncology. Additionally, the conference features the “Gianni Bonadonna Prize” for young investigators in innovative oncologic therapies, marking the 10th anniversary of Gianni Bonadonna’s passing and honoring his legacy as a founder of modern oncology.

Read Full Programme here.
